Sort by
Refine Your Search
-
Category
-
Field
-
-process and release testing of GMP Manufacturing and analytical development for cellular immunotherapy products. This is a fast-paced lab involved in cutting edge technology, research and clinical cellular
-
seeking a Research Associate II to join the T Cell Therapeutics Research Laboratory. This role involves fast-paced research in cutting-edge technology, immunotherapeutic programs, and a commitment to
-
qualifications: Bachelor’s or Master’s degree in molecular biology, cell biology, engineering, biology, chemistry, or related field. Tissue culture with cell lines and primary cells. Molecular biology techniques
-
of reproducible research Development of novel statistical methodologies Delivering talks on the results of the research Maintaining current knowledge of and contributing to advancements in the field through
-
complex biology research experiments. As a successful candidate, you will: Characterize engineered natural killer (NK) cells and patient samples. Possess pathology knowledge and proficiency in various
-
and practices and under the direction of the scientist in charge Effective communication of data and project updates using Microsoft excel, Powerpoint presentations and Google docs. Training of interns
-
. · Cooperates with other performance improvement and compliance activities within the department and in the institution. · Maintains current knowledge of analytical techniques and industry practices
-
registered; maintains documentation of participant registration. Conduct protocol management for an assigned set of multiple research protocols. Maintain current and accurate protocol documentation; notifies
-
current and accurate protocol documentation; notify investigators of pertinent protocol changes. Maintain and complete regulatory documents for IRB, DSMB, and PRMC/CPRMC. Compile and submit data
-
and cellular biology approaches to diabetes and obesity research, with an ultimate goal to unravel circadian etiologies underlying the current epidemics of metabolic diseases for targeted therapeutic